These discoveries illuminate the mechanism of a C3-independent C5 activation induced by chlamydial infection, and furthermore provide a potential therapeutic target and drug for preventing tubal fibrosis caused by chlamydial infection. This evidence concerns the gene C3 and chlamydia trachomatis infectious disease.